Abstract: As eries of structurally related mono-a nd bis-NHC-iridium(I) (NHC:N -heterocyclic carbene) complexes have been investigatedfor their suitability as potential anticancer drugs.T heir spectral behaviour in aqueous buffers under physiological-like conditions and their cytotoxicity againstt he cancerc ell lines MCF-7 and HT-29a re reported. Notably,almostall complexes exhibit significant cytotoxic effects towards both cancer cell lines. In general,t he cationic bis-carbene complexes show highers tabilitya nd greater anticancera ctivity than their neutral mono-carbene analogues with IC 50 valuesi nt he high nanomolar range.F urthermore, to gain initialm echanistic insight, the interactions of these iridium(I)-NHC complexes with two model proteins,n amely lysozyme and cytochrome c, were exploredb yH R-ESI-MS analyses. The different protein metalation patternso ft he complexes can be roughlyc lassified into two distinct groups. Those interactions give us af irst idea about the possible mechanism of action of this class of compounds. Overall, our findings show that iridium(I)-NHC complexesr epresent very interesting candidates forf urther development as new metal-based anticancer drugs.
Introduction
In the field of chemotherapy,t he metal-containing compound cisplatin and its derivatives carboplatin and oxaliplatin are currently used in more than 50 %o fa ll cancer treatments. [1] Despite their great success, Pt-basedc hemotherapeutics still bear severald rawbacks, such as ar emarkable toxicity against healthyc ells and the development of platinum-resistant tumors. [2, 3] These disadvantages underlinet he urgent need for furtherdevelopment of new anticancer drugs.
Organometallic compounds are amongt he most promising candidates in this area of research. [4] [5] [6] [7] [8] Due to their wide range of coordination numbersa nd geometries they offer ag reat structuralv ariety and, accordingly,alarge variety of biological mechanisms. Indeed, as uitable ligand combinedw ith the appropriate metal centreo ften allows af ine-tuningo ft he anticancer activity with higher cancers electivity.C oncerning the ligand system, N-heterocyclic carbenes (NHCs) have attracted great attentiono wing to their high stability and facility of derivatisation. Thus, in recent years, al arge number of metal-NHC complexes has been synthesised, and investigated as prospective anticancer drugs. [9] [10] [11] [12] In particular,n umerousg old(I)-NHC complexes have shown remarkable antiproliferative effects against several cancercell lines. [13] [14] [15] [16] An interesting elementt hat has recently received significant attention is iridium. [5, [17] [18] [19] The majority of Ir compounds for biological investigationsf eature either cyclopentadienyl [20] [21] [22] (especially the Cp* ligand)ordiimine ligands. [23] [24] [25] The element, in all these compounds,isi ni ts + III oxidations tate. In this oxidationstate, Ir is one of the most kinetically inert metal ions that exist under physiological conditions. It is, therefore, highly unlikely that Ir III compounds will covalently interact with biomolecules. In contrast, iridium in the lower oxidation state + I is kinetically more reactive but, as yet, rather poorly investigated for applications in medicinal organometallic chemistry.A lthoughawide number of iridium(I)-NHC complexes is known, biological investigationsr emaine xtremelyr are. [26] In ar ecent publication, we reported on the cytotoxic activity of an ew iridium(I) complex containing as imple ligand system. [27] We discovered that our iridium(I) complex most likely causesi ts cytotoxic effects through binding to biologically relevantp roteins. However, it is indispensable to investigate ag reater number of iridium(I) complexes to establish afirst detailed structure-activity relationship (SAR).
This prompted us to synthesise, characterise and evaluate aw hole serieso fn ew iridium(I) compounds as prospective cytotoxic and anticancer agents. These compounds were prepared and screened for their cytotoxic activitya gainst two representative cancer cell lines. Particular attention was paid to the analysis of their behaviour and stability in solution,a nd to their interactions with proteins, which seems to be mechanistically relevant. In fact, we wanted to ascertain whether these metal complexes exert their biological actions as intact species or undergo chemical activation and transformation prior to performing their biological effect, thus behaving as classical prodrugs.
Results and Discussion

Synthesis and characterisation
The iridium(I)-NHC complexes in the present study were prepared according to well-established procedures,d epicted in Scheme 1. The ligands differ in the lipophilicity of their imidazole side-chains, in order to understand whether lipophilicity has as ignificant influence on the anticancer activity.F urther, Ir I -NHC compounds with chlorido ligands were compared to bis-NHC complexes devoid of such alabile ligand.
For the preparation of the mono-carbene complexes,t he respectives ilver carbene complexes were generated in situ by treatment of the imidazolium salts with 0.5 equivalents of Ag 2 O. Addition of [{Ir(COD)Cl} 2 ]l ed to the corresponding iridium carbenes. The products were purified by columnc hromatography andf ull characterisationw as carriedo ut using 1 HNMR and 13 CNMR spectroscopy,mass spectrometry and elemental analysis. The formation of the complexes was confirmed by the disappearance of the C2 proton signal in the 1 HNMR spectra and by as trong downfield shifto ft he C2 carbon signal in the 13 CNMR spectra. To obtain the iridium(I)-bis-carbene complexes, the mono-carbene complexes were reacted with the corresponding imidazoliums alt in the presence of 1equivalent of am ild base and purified by column chromatography.
1 HNMR and 13 CNMR spectroscopy and mass spectrometry confirmed the formation of the complexes with characteristic upfield shifts of the signals originating from the unsaturatedc yclooctadiene carbon atoms between 5a nd 10 ppm.
The carbonyl-substitutedi ridium(I) complexes [Ir(NHC)(-CO) 2 Cl] were obtained by passing carbon monoxide gas through as olution of the [Ir(NHC)(COD)Cl] complexes in dichloromethane at room temperature resulting in quantitative replacement of the COD ligand by two equivalents of CO.
Suitable crystals of complexes 2b and 4a for single-crystal X-ray diffraction analysisw ere obtained by slow diffusion of hexane into as olution of the complexesi nd ichloromethanea t 4 8C ( Figure 1 ).
Solution studies
When considering ap ossible use of iridium complexes as anticancer drugs, it is important to understand their behaviour in aqueous solutions. The solution behaviour of the compounds was therefore analysed by time-dependent UV/Vis absorption spectroscopy in DMSO and in aqueous buffers under physiological-like conditions. Final concentrations of 200 mm or 500 mm of the individual complexes were diluted in the reference buffer (20 mm ammonium acetate, pH 6.8 or 20 mm phosphate buffer,p H7.3) with an addition of DMSO (50 %f or 2a, 2b and 4a,a nd 10 %f or the bis-carbene complexes 3a-3e)d ue to poor water solubility.T he changes in the spectral profiles werem onitored over 48 ha tr oom temperature for all compounds (Figure 2) .
The neutralc omplexes bearing ac hlorido ligand show only small changes in their spectral profile in neat DMSO, expressed by ap rogressive decrease in absorption intensity.A ss hown in previousw ork, [27] the observed spectral changes for the complexesc an be traced back to the slow dioxygen-caused oxida- www.chemeurj.org tion presumably of Ir I to Ir III .A mongt he mono-carbene complexes, the order 2b> 4a> 2a is established for the stability of the complexes towards oxidation in DMSO, while in ammonium acetate buffer, 4a is less affected followed by 2b and 2a.
Substitution of the chlorido ligand by another NHC ligand greatly increases the stability towards oxidation in solution. The cationic compounds 3a-3e show no oxidationi nD MSO even upon diluting DMSO solutions with aqueous buffers. Spectral profiles of 3b and 3e are reported in the supporting information ( Figure S2-S8) .
Since the bis-carbene complexes show no oxidation by air in aqueous solutions, we conclude that the oxidation state + Ii s much more stable in this class of compounds. This was further probedb ye xposing them to an excess of hydrogen peroxide. To this end, the spectral change of the complexes in the presence of 10 equivalents of hydrogen peroxide over ap eriod of 18 hw as recorded. The intensity at the highest maximum in the visible range at 451 nm as af unction of time, with and withoutthe presence of H 2 O 2 for 3e,i sd epicted in Figure 3 .
The intensity is described as al inear dependenceo nt he time. In the absence of H 2 O 2 the intensity shows as teady behaviour.Adifferent behaviour is observed in the presence of 10 equivalents of H 2 O 2 .H ere, the intensity decreases to 65 % after 18 h, which can be traced back to ac hange of the oxidation state of iridium from Ir I to Ir III .
Antiproliferative activityi nvitro
The in vitro anticancer activity of the iridium complexes was determined in MCF-7 (human breasta denocarcinoma) and HT-29 (colon adenocarcinoma) cells using the MTT assay with an incubation time of 48 h(see Ta ble 1).
The biological activity of complexes 2d and 4b could not be studied since 2d showed poor solubility in DMSO and 4b decomposed too rapidlyu nder the assay conditions.
The neutral mono-carbene complexes 2a, 2b and 2c of the type [Ir(NHC)(COD)Cl] show moderate cytotoxicity in the low micromolar range against both cell lines. Replacement of the COD ligand in 2a by CO leads to an oteworthy decrease of the activity,r esulting in around4 -fold higher IC 50 values.
Remarkably,t he introductiono fasecond carbene ligand produces as trong increase of the cytotoxic effects towards both cell lines with IC 50 values in the high nanomolar range. Accordingly,t he bis-carbene complexes 3a, 3d and 3e show significantly higherc ytotoxicity than the well-established drug cisplatin. [28, 29] It is noted, that complexesc ontaining the more lipophilic pentamethylbenzenei nt heir side-chains (2a, 3a, 3d and 3e)i ng eneral feature as ignificantlyh igher antiproliferative activity against both cell lines in both the mono-and bis- [a] Examples of dose-response curves are provided in the SupportingI nformation (Figures S9-S12).
Chem.E ur.J.2016, 22,12487 -12494 www.chemeurj.org carbene series. In this respect, the less lipophilicc omplexes 3b and 3c show significantly lower IC 50 values, but still comparable to the value of cisplatin. In terms of structure-activity relationships,w ec an draw the followingc onclusion from the cytotoxicity data. The bis-carbene complexes remaint he most toxic derivativesi nt his class of compounds with IC 50 values below 1 mm.T he corresponding neutralm ono-carbene complexesd isplay antiproliferative activity in the low micromolar range, whereas exchange of the COD ligand by CO further reduces the cytotoxic activity.
Reactions with model proteins
The identification of possible biological targets of anticancer metallodrugs may give af irst insighti nto their mode of action. In ap reviouss tudy,w ec ould demonstrate that 2a shows adduct formation with different model proteins.T his binding occurs with simultaneous oxidation of Ir I to Ir III ,b yl oss of the chloridoand cyclooctadiene ligand.
The same protein metalation studies were performed for all compounds presented in this work for two major reasons. Firstly,w ew anted to addresst he question is adduct formation general between mono-carbene complexes and these proteins?T he second reasonw as our inquisitiveness whether also the more oxidation-resistant bis-carbene complexess how the same behaviour in spite of their greater stability and intriguingly higher antiproliferative effects.
Accordingly,t he reactivity of all new complexes with the proteins horse heart cytochrome ca nd hen egg white lysozyme (HEWL) has been systemically investigated. In this study, they serve primarily as small model proteins. However,b oth proteins are present in the human body as well and are involved in different cellular processes. Whereas cytochrome ci s mainly found in the membranes of mitochondria, lysozymei s an important part of the inherenti mmune system. The interaction betweent hese proteins and the metal complexes has been studied by using high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS), which allows rapid and straightforward identification and characterisation of the resulting metallodrug-protein adducts.S olutionso ft he complexes in ammonium acetate (10 %D MSO for compounds 3a-3 e; 50 %D MSO for 2a+ 2b+ + 4a)w erei ncubated with the protein (3:1 and 10:1 ratio) at 37 8C. At selected time points (24 h, 48 h, 72 h), aliquots were taken and analysed by HR-ESI-MS. All mono-carbene complexes show extensive adduct formation with both proteins.A mong these compound 4a appears to be the most reactive,p roducing the largest amounts of protein adducts as judged by the absolute intensity of the MS signals.
As an example, the mass spectrum of cytochrome ca fter incubation with 4a for 72 hi sd epicted in Figure 4 .
In total, two specific adducts could be identified. The assignments were provenb yc omparing the observed isotope patterns with the calculatedo nes. The adduct with the highest intensity belongs to the iridium(III)-NHC fragment binding to cytochromec with concurrent loss of the chlorido ligand and both carbonyl groups. This observation differs from the adduct formationw ith HEWL, in which one CO is still bound to the iridium centre (see Supporting Information, Figure S15 ). Another adduct formedb etween 4a and cytochrome cc an be assigned to the iridium(III)-NHC fragment containing only one DMSO molecule, most probably bound to the iridium centre.H owever,i na ll cases the oxidation state of iridium changes from + I to + III, whichisi ng ood agreement with our earlier work.
The mass spectra of the proteins incubated with the COD containing mono-carbene complexes 2a-c show the same main adducts corresponding to the iridium(III)-NHC fragment.
The substitution of chloride by another NHC ligand greatly increases thes tability in solution and reduces the reactivity with biomolecules. Accordingly, no adduct formation with either of the two model proteins was observed for the cationic bis-carbene complexes 3a-e by mass spectrometry even upon long incubation times and aprotein-complexratio of 1:10. (Examplesa re provided in the Supporting Information, Figures S13 and S14 .) It seems that substitution of the most labile chlorido ligand is the intial step for protein interactions, and is in fact required before oxidation of the iridium(I) centre to iridium(III).
Therefore, our findings strongly suggestt hat the loss of labile ligandss uch as chloride, followed by the oxidation of the metal centre, paves the way for protein binding. Clearly, this reactionc annoth appeni nt he bis-carbene complexes 3, which consequently do not interact with proteins easily.A pparently,p rotein binding results in ad rastic attenuation (but not loss) of the cytotoxic activity.O verall, these observations indicate different modes of actions for the neutralm ono-carbene complexes on the one hand, and fort he cationic bis-carbene complexes on the other hand. 
Conclusion
The synthesis, structural aspects, solution behaviour,a ntiproliferative activity and the interaction with model proteinsf or as eries of novel iridium(I)-NHC complexes were comprehensively investigated in this study.T he synthesised compounds can be roughlyc ategorised into two groups, that is, cationic and neutralI r I -NHC complexes. These two classes of compounds show markedly different behaviour in solution,a sw ell as different metalation behaviour with proteins.
Almost all investigated compounds show antiproliferative effects at least againstt wo representative cell lines, for which the cytotoxicity of the cationic compounds in the high nanomolar range stands out in particular.S olutions tudies of the latter revealed ah igh stability toward oxidation and no reaction with modelp roteins. Only the presence of an excess of H 2 O 2 leads to slow oxidation of Ir I to most likely Ir III .The neutral complexes however, undergo progressive oxidation in aerated solutions,b eing far less inert than their cationic counterparts both in DMSO and aqueous buffers. They bind to cytochrome ca nd lysozyme by oxidationt oI r III with simultaneous loss of chlorido and cyclooctadiene/carbonyl ligands. Both cytochromec as well as lysozyme, although having differentp roperties, are good modelsf or other protein targets. It is therefore reasonable to assume that these Ir I complexes with labile ligands have the potentialo fm etalating and altering cellular proteins,thus leadingt oirreversible cell damage and death.
The more oxidation-resistant cationic bis-carbene complexes, while showing no interactions with proteins, produce far greater cytotoxic effects. This is an indication for different modes of action for this respective class of compounds. While the neutral complexes seem to cause cell death throughi nteractions with several proteins (likely with little target specificity), the cationic complexes most probably exert their biological effect as intact molecules. Their higher activity may therefore arise from am ore effective targeting, since they might not react with other cellular components beforer eaching their actual target(s). Moreover,i ti sh ypothesised that they work by causing selectivem itochondrial damage, given their structures as large, delocalised lipophilic cations. In line with this thought, the highera ctivity of the more lipophilic derivatives in both series of compounds likely results from ab etter cellular uptake.
Experimental Section
General: Reactions were carried out under N 2 by using standard Schlenk techniques. All solvents were of analytical grade. Chemicals were obtained from commercial sources and used without further purification. 1 Ha nd 13 CNMR spectra were recorded at room temperature on Bruker DPX 200, DPX 250 and DRX 400 spectrometers, respectively, in deuterated solvents which were used as internal reference. The chemical shifts are reported in ppm (parts per million) relative to TMS. Coupling constants J,a re reported in Hz, multiplicities being marked as:s inglet (s), doublet (d), triplet (t) or multiplet (m). IR spectra were measured on aBruker Tensor 27 instrument equipped with an attenuated total reflection (ATR) unit at 4cm À1 resolution. ESI mass spectra were measured on aB ruker Esquire 6000 mass spectrometer.F AB and EI high resolution mass spectrometry were performed with aF isons VG Instruments Autospec spectrometer. High-resolution mass spectra were recorded with an LTQO rbitrap high-resolution mass spectrometer (Thermo Scientific, San Jose, CA, USA) equipped with ac onventional ESI source. The mass to charge relation (m/z)i sg iven as ad imensionless number.U V-Vis absorption spectra were recorded on aV arian Cary 50 spectrophotometer.E lemental analyses were carried out on aV ario EL (Elementar Analysensysteme GmbH, Hanau, D) in C, H, Nmode.
Cell culture and cytotoxicity: Dulbecco'sM odified Eagle'sM edium (DMEM), containing 10 %f etal calf serum, 1% penicillin and streptomycin, was used as growth medium. MCF-7 and HT-29 cells were detached from the wells with trypsin and EDTA, harvested by centrifugation and resuspended again in cell culture medium. The assays have been carried out on 96 well plates with 6000 cells per well for both cell lines, MCF-7 and HT-29. After 24 ho fi ncubation at 37 8Ca nd 10 %C O 2 ,t he cells were treated with the compounds (with DMSO concentrations of 0.5 %) with af inal volume of 200 mL per well. For an egative control, one series of cells was left untreated. The cells were incubated for 48 hf ollowed by adding 50 mL MTT (2.5 mg mL À1 ). After an incubation time of 2h,t he medium was removed and 200 mLD MSO were added. The formazan crystals were dissolved and the absorption was measured at 550 nm, using ar eference wavelength of 620 nm. Each test was repeated in quadruplicates in three independent experiments for each cell line.
Interaction with cytochrome c( lysozyme): Solutions of the compounds (100 mm)w ith cytochrome c( lysozyme) (10:1 complex/protein molar ratio) in 10 %( 50 %) ammonium acetate buffer (20 mm, pH 6.8) and 90 %( 50 %) DMSO were incubated at 37 8C. After 24 h (48 h, 72 h) and 20-fold dilution with water ESI MS spectra were recorded by direct introduction at 5 mLmin À1 flow rate in an Orbitrap high-resolution mass spectrometer (Thermo, San Jose, CA, USA), equipped with ac onventional ESI source. The working conditions were as follows:s pray voltage 3.1 kV,c apillary voltage 45 V, capillary temperature 220 8C, tube lens voltage 230 V. The sheath and the auxiliary gases were set, respectively,a t1 7( arbitrary units) and 1( arbitrary units). For acquisition, Xcalibur 2.0. software (Thermo) was used and monoisotopic and average deconvoluted masses were obtained by using the integrated Xtract tool. For spectrum acquisition an ominal resolution (at m/z 400) of 100 000 was used. Synthesis of 1d:T oaflame-dried schlenk flask, NaH (24.0 mg, 1.0 mmol) was dissolved in dry THF (20 mL). After 10 min imidazole (68.2 mg, 1.0 mmol) was added and the mixture was stirred for 15 min. Then 1-(chloromethyl)-2,3,4,5,6-pentamethylbenzene (393.4 mg, 2.0 mmol) was added and the reaction mixture was stirred for another 30 min. Water (50 mL) and diethyl ether (50 mL) were added, the phases were separated and the aqueous phase was extracted with diethyl ether (2 50mL). The combined organic phases were washed with water and dried over magnesium sulfate. The residue was purified by column chromatography on silica gel using mixtures of dichloromethane/methanol to give 1d (289 mg, 68.0 %) of aw hite solid. General method for [Ir(COD)(NHC)(Cl)]-method A:ASchlenk flask was charged with the imidazolium salt and 0.5 equivalents of silver oxide in dry dichloromethane and stirred at r.tf or 1h. 0.5 equivalents of [{Ir(COD)Cl} 2 ]w as added and the resulting mixture was stirred for 24 h. The resulting suspension was filtered through celite, and the filtrate was concentrated to dryness. The crude product was purified by column chromatography on silica using mixtures of dichloromethane and methanol. N-CH=CH-N + .
General method for [Ir(COD)(NHC) 2 ]-method B:AS chlenk flask was charged with [Ir(COD)(NHC)(Cl)],t he corresponding imidazolium salt and 1equivalent of K 2 CO 3 in dry dichloromethane and stirred at RT for 48 h. The resulting suspension was filtered through celite and the filtrate was concentrated to dryness. The crude product was purified by column chromatography on silica using mixtures of dichloromethane and methanol. General method for [Ir(CO) 2 (NHC)(Cl)]-method C:T he corresponding [Ir(COD)(NHC)(Cl)] complex was dissolved in dichloromethane and CO gas was passed through the solution for 10 min. The solution was evaporated to dryness at RT and the remaining solid was dried in vacuo. Data for 4b synthesised by method C:C ompound 2b (140 mg, 294 mmol), gave 4b (124.6 mg, 100 %) as as light yellow solid;
